Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 995

1.

Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.

Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.

J Biomater Appl. 2008 Jan;22(4):353-71. Epub 2007 May 10.

PMID:
17494965
2.

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

Ravi Kumar MN, Bakowsky U, Lehr CM.

Biomaterials. 2004 May;25(10):1771-7.

PMID:
14738840
3.

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.

Tahara K, Yamamoto H, Hirashima N, Kawashima Y.

Eur J Pharm Biopharm. 2010 Mar;74(3):421-6. doi: 10.1016/j.ejpb.2009.12.007. Epub 2009 Dec 23.

PMID:
20034563
5.

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM.

Nanomedicine. 2007 Sep;3(3):173-83. Epub 2007 Aug 9.

PMID:
17692575
6.

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.

Zeng P, Xu Y, Zeng C, Ren H, Peng M.

Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.

PMID:
21645597
7.

Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.

Tahara K, Furukawa S, Yamamoto H, Kawashima Y.

Int J Pharm. 2010 Jun 15;392(1-2):311-3. doi: 10.1016/j.ijpharm.2010.03.042. Epub 2010 Mar 25.

PMID:
20347023
8.
9.

Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.

Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y.

Biomaterials. 2011 Jan;32(3):870-8. doi: 10.1016/j.biomaterials.2010.09.034.

PMID:
20934748
10.
11.

Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.

Takashima Y, Saito R, Nakajima A, Oda M, Kimura A, Kanazawa T, Okada H.

Int J Pharm. 2007 Oct 1;343(1-2):262-9. Epub 2007 May 26.

PMID:
17628365
12.

Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.

Niu X, Zou W, Liu C, Zhang N, Fu C.

Drug Dev Ind Pharm. 2009 Nov;35(11):1375-83. doi: 10.3109/03639040902939221.

PMID:
19832638
13.

The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.

Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.

Pharm Res. 2010 Jul;27(7):1285-95. doi: 10.1007/s11095-010-0103-0. Epub 2010 Mar 23.

PMID:
20309616
14.
15.

The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.

Kim BS, Kim CS, Lee KM.

Arch Pharm Res. 2008 Aug;31(8):1050-4. doi: 10.1007/s12272-001-1267-5. Epub 2008 Sep 12.

PMID:
18787796
16.

Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.

Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P.

Int J Pharm. 2011 Jan 17;403(1-2):276-84. doi: 10.1016/j.ijpharm.2010.10.040. Epub 2010 Oct 29.

PMID:
21044878
17.

Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.

Nie H, Wang CH.

J Control Release. 2007 Jul 16;120(1-2):111-21. Epub 2007 Apr 1.

PMID:
17512077
18.
19.

Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.

Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.

Int J Pharm. 2009 Dec 1;382(1-2):198-204. doi: 10.1016/j.ijpharm.2009.07.023. Epub 2009 Jul 29.

PMID:
19646519
20.

Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles.

Cegnar M, Kos J, Kristl J.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3087-94.

PMID:
17048522

Supplemental Content

Support Center